Opioid activities and structures of alpha-casein-derived exorphins.
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Exorphins, peptides with opioid activity, have previously been isolated from pepsin hydrolysates of alpha-casein [Zioudrou, C., Streaty, R. A., & Klee, W. A. (1979) J. Biol. Chem. 254, 2446-2449]. Analysis of these peptides shows that they correspond to the sequences 90-96, Arg-Tyr-Leu-Gly-Tyr-Leu-Glu, and 90-95, Arg-Tyr-Leu-Gly-Tyr-Leu, of alpha-casein. These peptides, as well as two of their analogues Tyr-Leu-Gly-Tyr-Leu-Glu (91-96) and Tyr-Leu-Gly-Tyr-Leu (91-95), have now been synthesized and characterized. Their opioid activity was examined by three different bioassays: (a) displacement of D-2-alanyl[tyrosyl-3,5-3H]enkephalin-(5-L-methioninamide) and [3H]dihydromorphine from rat brain membranes; (b) naloxone-reversible inhibition of adenylate cyclase in homogenates of neuroblastoma x glioma hybrid cells; (c) naloxone-reversible inhibition of electrically stimulated contractions of the mouse vas deferens. The synthetic peptide of sequence 90-96 was the most potent opioid in all three bioassays and its potency was similar to that of the isolated alpha-casein exorphins. The synthetic peptides were totally resistant to hydrolysis by trypsin and homogenates of rat brain membranes, but were partially inactivated by chymotrypsin and subtilisin. The difference in opioid activity of alpha-casein exorphins may be related to differences in conformational flexibility observed by NMR spectroscopy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The best studied myorelaxant peptides are beta-casomorphins (which act on the mu receptors) and alpha s1 casein-derived peptide (which acts on the delta receptor).”
From Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines (2016) · cites this paper as Loukas et al., 1983
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor
Nakanishi, S., Inoue, A., Kita, T., Inoue, A., Nakamura, M., Chang, A. C. Y., Cohen, S. N., & Numa, S. (1979) · Nature · doi:10.1038/278423a0 · Cited by 1,762
The Use of Esters of N-Hydroxysuccinimide in Peptide Synthesis
Anderson, G. W., Zimmerman, J. E., & Callahan, F. M. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01063a037 · Cited by 1,240
Strategy and tactics in protein chemistry
Hartley, B. S. (1970) · Biochemical Journal · doi:10.1042/bj1190805f · Cited by 1,225
Common precursor to corticotropins and endorphins
Mains, R. E., Eipper, B. A., & Ling, N. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.7.3014 · Cited by 1,105
Dynorphin-(1-13), an extraordinarily potent opioid peptide.
Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M., & Hood, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6666 · Cited by 882
Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor
Kakidani, H., Furutani, Y., Takahashi, H., Noda, M., Morimoto, Y., Hirose, T., Asai, M., Inayama, S., Nakanishi, S., & Numa, S. (1982) · Nature · doi:10.1038/298245a0 · Cited by 783
Lewis, P. N., Momany, F. A., & Scheraga, H. A. (1973) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(73)90350-4 · Cited by 659
Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands.
Li, C. H., & Chung, D. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.4.1145 · Cited by 637
Cited by
Bioactive milk peptides: a prospectus.
Clare, D. A., & Swaisgood, H. E. (2000) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(00)74983-6 · Cited by 718
Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows.
Pessione, E. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00086 · Cited by 592
“The N-terminal residue, which is crucial for triggering biological activity, is Tyr in beta-casomorphins and Arg in alpha s1 casein-derived peptide (Loukas et al., 1983).”
Caseins as source of bioactive peptides
Silva, S. V., & Malcata, F. X. (2005) · International Dairy Journal · doi:10.1016/j.idairyj.2004.04.009 · Cited by 436
“…sequences in the primary structure of caseins Casein type Peptide sequence Amino-acid segment References Agonistic peptides as1 (bovine) 90–95 RYLGYL Loukas et al. (1983) 90–96 RYLGYLE Loukas et al. (1983) 91–95 YLGYL Loukas et al. (1983) b (human) 41–44 YPSFQ Fiat et al. (1993) g (casein) 114–121…”
BackgroundInfluentialEffects of milk-derived bioactives: an overview
Shah, N. P. (2000) · British Journal of Nutrition · doi:10.1017/s000711450000218x · Cited by 403
“Two opioid antagonists, casoxin C and D also belong to this group (Loukas et al. 1983).”
Swaisgood, H. E. (2003) · Advanced Dairy Chemistry—1 Proteins · doi:10.1007/978-1-4419-8602-3_3 · Cited by 383
Metadata
- Authors
- Loukas, S., Varoucha, D., Zioudrou, C., Streaty, R. A., & Klee, W. A.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1983-09-13
- Volume
- 22
- Issue
- 19
- Pages
- 4567-4573
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2006944115
- Cited by
- 167
- References
- 33
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 7 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 4 · 2015: 4 · 2014: 3 · 2013: 8 · 2012: 5
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Agricultural and Biological Sciences › Food Science › Protein Hydrolysis and Bioactive Peptides
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- exorphins, alpha-casein, opioid activity, synthetic peptides, enkephalin analogs, peptide conformational flexibility, chymotrypsin, subtilisin, trypsin, adenylate cyclase, vas deferens contraction
- MeSH terms
- Adenylyl Cyclase Inhibitors, Amino Acid Sequence, Animals, Biological Assay, Brain, Caseins, Cell Line, Hydrolysis, Indicators and Reagents, Kinetics, Magnetic Resonance Spectroscopy, Pepsin A, Peptides, Receptors, Opioid, Synaptic Membranes, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.